pentobarbital will reduce the extent or outcome of celecoxib by affecting hepatic enzyme CYP2C9/10 metabolism. Slight/Significance Unfamiliar. Contraindicated (one)pentobarbital will lower the extent or effect of lorlatinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Immediately